Abstract |
Antigen isolated from Immunoselected Melanoma-2 (AIM-2) was recently identified using melanoma-reactive CD8 T cells. AIM-2 antigen is expressed in a wide variety of tumor types, including neuroectodermal tumors, as well as breast, ovarian and colon carcinomas. In this study, we analyzed AIM-2 expression in glioblastoma multiforme (GBM) in primary cultured cells and established GBM cell lines. We found that the primary GBM cell lines expressed 88.4% and 93.0% of non-spliced and spliced AIM-2, respectively. Five out of seven of the established GBM cell lines expressed both non-spliced and spliced AIM-2. Furthermore, the C9 CTL clone, which is specific for AIM-2 peptide (RSDSGQQARY), efficiently recognized GBM tumor cells in an antigen-specific and HLA-A1 restricted manner. IFN-gamma treatment of the GBM tumor cells dramatically increased HLA-A1 expression levels and, consequently, increased CTL recognition of the treated tumor cells. More importantly, seven out of 12 HLA-A1 and AIM-2 positive patients from our dendritic cell clinical trial generated AIM-2 specific CTL activity in their PBMC after vaccinations. These data indicate that AIM-2 could be used as a tumor antigen target for monitoring vaccine trials or to develop antigen specific active immunotherapy for glioma patients.
|
Authors | Gentao Liu, John S Yu, Gang Zeng, Dong Yin, Dong Xie, Keith L Black, Han Ying |
Journal | Journal of immunotherapy (Hagerstown, Md. : 1997)
(J Immunother)
2004 May-Jun
Vol. 27
Issue 3
Pg. 220-6
ISSN: 1524-9557 [Print] United States |
PMID | 15076139
(Publication Type: Journal Article)
|
Chemical References |
- AIM2 protein, human
- Antigens, Neoplasm
- DNA, Complementary
- DNA-Binding Proteins
- HLA-A1 Antigen
- Nuclear Proteins
- Peptides
- RNA, Messenger
- RNA
- Interferon-gamma
|
Topics |
- Antigens, Neoplasm
- Brain Neoplasms
(metabolism)
- Cell Line, Tumor
- DNA, Complementary
(metabolism)
- DNA-Binding Proteins
- Dendritic Cells
(cytology, immunology)
- Enzyme-Linked Immunosorbent Assay
- Glioblastoma
(metabolism)
- Glioma
(metabolism)
- HLA-A1 Antigen
(chemistry)
- Humans
- Immunotherapy
(methods)
- Interferon-gamma
(metabolism)
- Leukocytes, Mononuclear
(metabolism)
- Nuclear Proteins
(biosynthesis, chemistry)
- Peptides
(chemistry)
- RNA
(chemistry)
- RNA, Messenger
(metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
- T-Lymphocytes, Cytotoxic
(metabolism)
- Time Factors
- Up-Regulation
|